Apices

Executive Summary

Apices is a private Spanish biotechnology company headquartered in Barcelona, founded in 2016. The company specializes in developing innovative drug delivery technologies and formulations for small molecule therapeutics, aiming to improve drug efficacy, safety, and patient compliance. With a focus on proprietary delivery platforms, Apices seeks to address key challenges in pharmaceutical development, potentially enabling better pharmacokinetics and reduced side effects for existing and novel drugs. Despite limited public information and no disclosed pipeline or funding details, the company's niche in drug delivery positions it within a competitive but high-value sector of the biopharma industry.

Upcoming Catalysts (preview)

• Q4 2026First preclinical proof-of-concept data for lead delivery platform40% success
• 2027Potential strategic partnership or licensing deal with a larger pharma30% success
• 2026Series A funding round to advance pipeline25% success